IL22 and colorectal carcinoma: Increased IL-17 can effectively promote the expression of STAT3 and AHR transcription factors in intestinal innate lymphocyte 3 (ILC3), which in turn leads to the increase of IL-22 and promotes the proliferation of intestinal epithelial cells and the progress of CRC (Zhu et al., 2021).